1. Home
  2. IOVA vs KTOS Comparison

IOVA vs KTOS Comparison

Compare IOVA & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$7.41

Market Cap

6.7B

Sector

Health Care

ML Signal

N/A

Logo Kratos Defense & Security Solutions Inc.

KTOS

Kratos Defense & Security Solutions Inc.

N/A

Current Price

$29.95

Market Cap

6.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
IOVA
KTOS
Founded
2007
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.3B
IPO Year
2008
1999

Fundamental Metrics

Financial Performance
Metric
IOVA
KTOS
Price
$7.41
$29.95
Analyst Decision
Buy
Strong Buy
Analyst Count
9
25
Target Price
$14.50
★ $74.68
AVG Volume (30 Days)
★ 12.8M
4.5M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
14.84
★ 18.18
EPS
N/A
★ 0.09
Revenue
N/A
★ $751,900,000.00
Revenue This Year
$58.86
$33.53
Revenue Next Year
$41.86
$22.53
P/E Ratio
★ N/A
$329.39
Revenue Growth
N/A
★ 12.44
52 Week Low
$2.08
$29.29
52 Week High
$15.37
$134.00

Technical Indicators

Market Signals
Indicator
IOVA
KTOS
Relative Strength Index (RSI) 31.10 27.83
Support Level $3.57 N/A
Resistance Level $9.36 $50.59
Average True Range (ATR) 0.57 2.36
MACD -0.13 -0.61
Stochastic Oscillator 4.34 0.09

Price Performance

Historical Comparison
IOVA
KTOS

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About KTOS Kratos Defense & Security Solutions Inc.

Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.

Share on Social Networks: